or Try an Advanced Search...

    Technical Analysis for KYMR - Kymera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 44.54 1.14% 0.50
    KYMR closed up 1.14 percent on Friday, July 26, 2024, on 60 percent of normal volume.
    Earnings due: Aug 1
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Flat
    Historical KYMR trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 1.14%
    Doji - Bullish? Reversal 3.87%
    Outside Day Range Expansion 3.87%
    Wide Bands Range Expansion 3.87%
    Wide Bands Range Expansion 2.44%
    Wide Bands Range Expansion 4.87%
    Down 3 Days in a Row Weakness 4.87%
    Down 4 Days in a Row Weakness 4.87%
    Older End-of-Day Signals for KYMR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 10 hours ago
    Possible Inside Day about 10 hours ago
    60 Minute Opening Range Breakout about 10 hours ago
    Up 2% about 10 hours ago
    Down 1% about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KYMR Chart by TradingView
    Basic chart:

    Profile

    Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa

    Is KYMR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 25 We're Not Worried About Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn
    Jul 16 Kymera Therapeutics: Solid Progress And No Change To My 'Buy' Rating
    Jul 14 XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
    Jul 11 Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
    Jul 10 Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
    Jul 9 Why Kymera Therapeutics Stock Is Soaring Today
    Jul 9 Kymera Therapeutics soars as Sanofi expands phase 2 trials
    Jul 9 Kymera Therapeutics Soars as Sanofi Expands Studies of Its Skin Diseases Drug
    Jul 9 Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
    Jul 9 Biggest stock movers today: BP, INTC, HELE, and more
    See more KYMR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 48.7
    52 Week Low 9.6
    Average Volume 647,223
    200-Day Moving Average 30.78
    50-Day Moving Average 35.62
    20-Day Moving Average 39.25
    10-Day Moving Average 44.46
    Average True Range 2.65
    RSI (14) 63.64
    ADX 38.2
    +DI 30.54
    -DI 12.28
    Chandelier Exit (Long, 3 ATRs) 40.75
    Chandelier Exit (Short, 3 ATRs) 37.19
    Upper Bollinger Bands 51.72
    Lower Bollinger Band 26.78
    Percent B (%b) 0.71
    BandWidth 63.56
    MACD Line 2.93
    MACD Signal Line 2.66
    MACD Histogram 0.2664
    Fundamentals Value
    Market Cap 2.64 Billion
    Num Shares 59.4 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -15.57
    Price-to-Sales 46.41
    Price-to-Book 5.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 47.57
    Resistance 3 (R3) 47.49 46.41 47.07
    Resistance 2 (R2) 46.41 45.64 46.45 46.90
    Resistance 1 (R1) 45.47 45.16 44.93 45.55 46.73
    Pivot Point 44.39 44.39 44.12 44.43 44.39
    Support 1 (S1) 43.45 43.62 42.91 43.53 42.35
    Support 2 (S2) 42.37 43.14 42.41 42.18
    Support 3 (S3) 41.43 42.37 42.02
    Support 4 (S4) 41.51